Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-alpha-MSH4-11-NH2: a superpotent melanotropin with prolonged biological activity
- PMID: 6608041
- DOI: 10.1016/0024-3205(84)90302-3
Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-alpha-MSH4-11-NH2: a superpotent melanotropin with prolonged biological activity
Abstract
Ac-[Nle4, D-Phe7]-alpha-MSH4-11-NH2 an octapeptide, is a melanotropin analogue (Ac-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-NH2), which is a superpotent agonist of frog and lizard skin melanocytes and mouse S 91 (Cloudman) melanoma cells. This melanotropin possesses ultraprolonged activity on melanocytes, both in vitro and in vivo, and the peptide is resistant to inactivation by serum enzymes. The tritium-labeled congener was prepared by direct incorporation of [3H]-labeled norleucine into the peptide. The melanotropic activity of the labeled peptide is identical to the unlabeled analogue. This labeled peptide should be useful for studies on the localization and characterization of melanotropin receptors.
Similar articles
-
Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.J Med Chem. 1989 Dec;32(12):2555-61. doi: 10.1021/jm00132a010. J Med Chem. 1989. PMID: 2555512
-
Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.Biochem Biophys Res Commun. 1986 Jun 13;137(2):722-8. doi: 10.1016/0006-291x(86)91138-1. Biochem Biophys Res Commun. 1986. PMID: 3089218
-
Synthesis and biological evaluation of the superagonist [N alpha-chlorotriazinylaminofluorescein-Ser1,Nle4,D-Phe7]-al pha-MSH.J Pharm Sci. 1985 Mar;74(3):237-40. doi: 10.1002/jps.2600740303. J Pharm Sci. 1985. PMID: 2989482
-
[Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin with prolonged action on vertebrate chromatophores.Comp Biochem Physiol A Comp Physiol. 1985;81(1):1-6. doi: 10.1016/0300-9629(85)90259-2. Comp Biochem Physiol A Comp Physiol. 1985. PMID: 2859941
-
The bio-organic chemistry of alpha-melanotropin.Med Res Rev. 1982 Jul-Sep;2(3):247-70. doi: 10.1002/med.2610020303. Med Res Rev. 1982. PMID: 6811810 Review. No abstract available.
Cited by
-
Peptide-Based Strategies for Targeted Tumor Treatment and Imaging.Pharmaceutics. 2021 Apr 2;13(4):481. doi: 10.3390/pharmaceutics13040481. Pharmaceutics. 2021. PMID: 33918106 Free PMC article. Review.
-
Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.Front Oncol. 2013 Sep 25;3:247. doi: 10.3389/fonc.2013.00247. Front Oncol. 2013. PMID: 24093086 Free PMC article. Review.
-
Tritium Labeling of Neuromedin S by Conjugation with [3H]N-Succinimidyl Propionate.ACS Omega. 2023 Jan 4;8(2):2367-2376. doi: 10.1021/acsomega.2c06758. eCollection 2023 Jan 17. ACS Omega. 2023. PMID: 36687043 Free PMC article.
-
Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues.G Ital Dermatol Venereol. 2010 Apr;145(2):245-58. G Ital Dermatol Venereol. 2010. PMID: 20467398 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources